Kotenko, Sergei V

Role of deficient type III interferon-λ production in asthma exacerbations

Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine

interferon and immune responsesAsthma and respiratory diseases

Cited by 1,006

Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types

Dumoutier, L., Leemans, C., Lejeune, D., Kotenko, S. V., & Renauld, J.-C. (2001) · The Journal of Immunology

Cytokine Signaling Pathways and InteractionsPsoriasis: Treatment and Pathogenesis

Cited by 405

The Human Homologue of the Yeast Proteins Skb1 and Hsl7p Interacts with Jak Kinases and Contains Protein Methyltransferase Activity

Pollack, B. P., Kotenko, S. V., He, W., Izotova, L. S., Barnoski, B. L., & Pestka, S. (1999) · Journal of Biological Chemistry

Cancer-related gene regulationGenomics and Chromatin Dynamics

Cited by 290

The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain

Donnelly, R. P., Sheikh, F., Kotenko, S. V., & Dickensheets, H. (2004) · Journal of Leukocyte Biology

Cytokine Signaling Pathways and InteractionsPsoriasis: Treatment and Pathogenesis

Cited by 289

Identification, Cloning, and Characterization of a Novel Soluble Receptor That Binds IL-22 and Neutralizes Its Activity

Kotenko, S. V., Izotova, L. S., Mirochnitchenko, O. V., Esterova, E., Dickensheets, H., Donnelly, R. P., & Pestka, S. (2001) · The Journal of Immunology

Cytokine Signaling Pathways and InteractionsPsoriasis: Treatment and Pathogenesis

Cited by 260

Type III interferon is a critical regulator of innate antifungal immunity

Espinosa, V., Dutta, O., McElrath, C., Du, P., Chang, Y.-J., Cicciarelli, B., Pitler, A., Whitehead, I., Obar, J. J., Durbin, J. E., et al. (2017) · Science Immunology

interferon and immune responsesNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 202

Phosphoinositide 3-kinase signaling can modulate MHC class I and II expression

Chandrasekaran, S., Sasaki, M., Scharer, C. D., Kissick, H. T., Patterson, D. G., Magliocca, K. R., Seykora, J. T., Sapkota, B., Gutman, D. A., Cooper, L. A., et al. (2019) · Molecular Cancer Research

PI3K/AKT/mTOR signaling in cancerCancer Immunotherapy and Biomarkers

Cited by 61